3D printed cornea restores sight for the first time in the world

3D printed cornea restores sight for the first time in the world

NEWNow you can listen to News articles!

The surgeons at Rambam Eye Institute have made medical history.

They restored sight to a legally blind patient using a fully 3D-printed corneal implant grown entirely from cultured human corneal cells. This was the first time a corneal implant that did not rely on donated tissue was transplanted into a human eye.

Sign up to receive my FREE CyberGuy report
Get my best tech tips, urgent security alerts, and exclusive offers delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Guide to Surviving Scams, free when you join me CYBERGUY.COM information sheet.

A breakthrough that turns one donor corneas into hundreds

The cornea came from a healthy deceased donor and was then multiplied in the laboratory. The researchers used the cultured cells to print around 300 transparent implants with Precise Bio’s regenerative platform.

Their system builds a layered structure that looks and behaves like a natural cornea. It is designed to provide long-term clarity, strength and function.

HOW A SMALL RETINA IMPLANT HELPS PEOPLE RESTORE THEIR SIGHT

As donor shortages prevent millions of people from receiving sight-saving care each year, this approach could transform access. Many patients in developed countries wait only a few days for a transplant, while others wait years due to low availability of tissue. A single-donor cornea that can create hundreds of implants changes that equation.

Medical staff in surgical gowns gather around equipment during a procedure in an operating room.

The surgery used a fully 3D-printed corneal implant grown from cultured human cells and restored sight to a legally blind patient. (Rambam Eye Institute)

The surgery that proved it works

Professor Michael Mimouni, director of the Cornea Unit in the Department of Ophthalmology at Rambam Eye Institute, led the surgical team. He described the moment as unforgettable because the lab-created implant restored sight to a real patient for the first time.

He says: “What this platform shows and proves is that in the lab you can expand human cells. Then print them in whatever layer you need and that tissue will be sustainable and work. Hopefully we can reduce wait times for all types of patients waiting for all types of transplants.”

The procedure is part of an ongoing Phase 1 clinical trial evaluating safety and tolerability in people with corneal endothelial disease. This achievement reflects years of work in research laboratories, operating rooms and industry. It also shows how coordinated teams can advance new treatments from concept to clinical reality.

How science fits into a bigger future

The trailer will have a permanent home at Rambam’s upcoming Helmsley Health Discovery Tower. The new Eye Institute will consolidate care, training and research under one roof. Its goal is to accelerate the move from emerging science to real-world treatment for patients throughout northern Israel and beyond.

Precise Bio says its 3D printing system could eventually support other tissues such as heart muscle, liver and kidney cells. That future will require lengthy testing and extensive validation, but the path now appears more achievable.

POPULAR WEIGHT LOSS MEDICATIONS LINKED TO SUDDEN VISION LOSS, RESEARCH SUGGESTS

A surgeon in a blue coat speaks inside a brightly lit operating room with medical equipment behind him.

Professor Michael Mimouni led the surgical team at the Rambam Eye Institute Cornea Unit. (Rambam Eye Institute)

What does this mean to you?

If corneal disease affects someone in your family, this work gives you new hope. Donor tissue may still play a role in many regions, but lab-grown implants offer a way to expand access where shortages hold patients back. The success of this first transplant also suggests a future in which regenerative medicine supports many types of tissue repair.

This milestone also shows how long it takes for scientific advances to reach real patients. The first 3D printed cornea design appeared in 2018 and has only now reached human use. Still, progress feels rapid when the result is vision recovery.

Take my quiz: How safe is your online security?

Do you think your devices and data are really protected? Take this quick quiz to see where you stand digitally. From passwords to Wi-Fi settings, you’ll get a personalized breakdown of what you’re doing well and what you need to improve. Take my quiz here: Cyberguy.com.

EYE DROPS CAN REPLACE READING GLASSES FOR THOSE FIGHTING AGE-RELATED VISION LOSS

Kurt’s Key Takeaways

This successful transplant marks a turning point for eye care. It suggests a world where donor supply limits do not decide who receives sight-saving surgery. As more trial results come in, we will see how far this technology can scale and which patients will benefit first.

If regenerative implants become common, what medical challenge should researchers focus on next? Let us know by writing to us at Cyberguy.com

A woman looks over her reading glasses at the book in her hands

The breakthrough shows how a donor cornea can generate hundreds of lab-created implants, offering new hope to people facing long waits for sight-saving treatment. (iStock)

CLICK HERE TO DOWNLOAD THE News APP

Sign up to receive my FREE CyberGuy report
Get my best tech tips, urgent security alerts, and exclusive offers delivered straight to your inbox. Plus, you’ll get instant access to my Ultimate Guide to Surviving Scams, free when you join me CYBERGUY.COM information sheet.

Copyright 2025 CyberGuy.com. All rights reserved.

Kurt “CyberGuy” Knutsson is an award-winning technology journalist with a deep love for technology, gear and devices that improve lives with his contributions to News and News Business since mornings on “News & Friends.” Do you have any technical questions? Get Kurt’s free CyberGuy newsletter, share your voice, a story idea or comment on CyberGuy.com.

Leave a Reply

Your email address will not be published. Required fields are marked *